RESUMEN
Although breast cancer is, unfortunately, not uncommon in women, a mere 0.04% of malignant breast tumours are primary angiosarcomas. Chemotherapy is advocated for treatment of breast angiosarcomas; however, no guidelines exist regarding optimal chemotherapeutics or protocols. Presently, the prognosis for breast angiosarcomas is poor. This case report describes a 24-year old woman diagnosed with primary breast angiosarcoma. She initially refused to receive treatment, but later returned to the hospital four years later with a haemopneumothorax. She was treated with rescue chemotherapy using a combination of high-dose tamoxifen plus ifosfamide and epirubicin (an anthracycline). She achieved a partial response, but died 16 months after therapy was initiated. More research is needed to devise novel chemotherapeutics and protocols to improve outcomes in women diagnosed with primary angiosarcomas ofthe breast.
Aunque el cáncer de mama, desafortunadamente, no es poco común en las mujeres, apenas 0.04% de los tumores malignos de mama son angiosarcomas primarios. La quimioterapia es el tratamiento de preferencia en los casos de angiosarcomas de mama. Sin embargo, no existen guías en relación con los protocolos o la quimioterapia óptima. En la actualidad, el pronóstico para los angiosarcomas de mama es pobre. Este informe del caso describe a una mujer de 24 años diagnosticada con angiosarcoma primario de mama. Inicialmente la paciente se negó a recibir tratamiento, pero volvió al hospital cuatro años más tarde con un hemoneumotórax. Fue tratada entonces con quimioterapia de rescate usando una combinación de alta dosis de tamoxifen con ifosfamida y epirrubicina (antraciclina). Llegó a responder parcialmente al tratamiento, pero falleció 16 meses después del inicio de la terapia. Se necesitan más investigaciones para elaborar nuevos quimioterápeuticos y protocolos que mejoren los resultados en los casos de mujeres diagnosticadas con angiosarcomas primarios de mama.
Asunto(s)
Humanos , Femenino , Adulto Joven , Neoplasias de la Mama/tratamiento farmacológico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Hemangiosarcoma/tratamiento farmacológico , Tamoxifeno/administración & dosificación , Resultado Fatal , Antraciclinas/administración & dosificación , Ifosfamida/administración & dosificaciónRESUMEN
PURPOSE: To investigate the clinical characteristics and pathological features of patients with mycobacterial tenosynovitis and arthritis. METHODS: All patients with tenosynovitis and arthritis caused by Mycobacterium tuberculosis (MTB) and nontuberculous mycobacteria (NTM) who were treated at a medical center in Taiwan from 2001 to 2010 were analyzed. RESULTS: Thirty-two patients with mycobacterial tenosynovitis and arthritis were identified. MTB was isolated exclusively from patients with arthritis of large joints (n = 11), while NTM were isolated from patients with arthritis of large joints (n = 4) and from those with tenosynovitis (n = 17). Among patients with tenosynovitis due to NTM, the most commonly found NTM were M. marinum (n = 7), M. intracellulare (n = 5), and M. abscessus (sensu stricto) (n = 2). Six of the seven patients with tenosynovitis due to M. marinum had suffered fishing-related injuries to the hands. All four patients with NTM arthritis had recurrent septic arthritis after surgery. NTM were isolated once from the debrided tissue specimens in three of these patients; the other patient died of systemic infection caused by M. intracellulare and multiple bacterial pathogens. CONCLUSION: Mycobacterial tenosynovitis should be considered in patients who present with indolent symptoms of chronic tenosynovitis. Complete clinical information, including history of trauma or joint replacement surgery and underlying systemic disease, is helpful in establishing an early diagnosis of the disease.
Asunto(s)
Artritis Infecciosa/patología , Infecciones por Mycobacterium no Tuberculosas/tratamiento farmacológico , Mycobacterium tuberculosis/aislamiento & purificación , Tenosinovitis/patología , Adulto , Anciano , Anciano de 80 o más Años , Antituberculosos/uso terapéutico , Artritis Infecciosa/microbiología , Artritis Infecciosa/cirugía , Femenino , Huesos del Pie/lesiones , Huesos del Pie/microbiología , Huesos del Pie/cirugía , Huesos de la Mano/lesiones , Huesos de la Mano/microbiología , Huesos de la Mano/cirugía , Humanos , Masculino , Persona de Mediana Edad , Infecciones por Mycobacterium no Tuberculosas/diagnóstico , Mycobacterium marinum/aislamiento & purificación , Mycobacterium marinum/patogenicidad , Recurrencia , Líquido Sinovial/microbiología , Taiwán , Tenosinovitis/microbiología , Adulto JovenRESUMEN
Although breast cancer is, unfortunately, not uncommon in women, a mere 0.04% of malignant breast tumours are primary angiosarcomas. Chemotherapy is advocated for treatment of breast angiosarcomas; however, no guidelines exist regarding optimal chemotherapeutics or protocols. Presently, the prognosis for breast angiosarcomas is poor. This case report describes a 24-year old woman diagnosed with primary breast angiosarcoma. She initially refused to receive treatment, but later returned to the hospital four years later with a haemopneumothorax. She was treated with rescue chemotherapy using a combination of high-dose tamoxifen plus ifosfamide and epirubicin (an anthracycline). She achieved a partial response, but died 16 months after therapy was initiated. More research is needed to devise novel chemotherapeutics and protocols to improve outcomes in women diagnosed with primary angiosarcomas of the breast.
Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias de la Mama/tratamiento farmacológico , Hemangiosarcoma/tratamiento farmacológico , Antraciclinas/administración & dosificación , Resultado Fatal , Femenino , Humanos , Ifosfamida/administración & dosificación , Tamoxifeno/administración & dosificación , Adulto JovenAsunto(s)
Distrofias Hereditarias de la Córnea/cirugía , Mutación , Queratectomía Fotorrefractiva/métodos , Factor de Crecimiento Transformador beta1/genética , Factor de Crecimiento Transformador beta1/metabolismo , Arginina , Distrofias Hereditarias de la Córnea/genética , Distrofias Hereditarias de la Córnea/patología , Femenino , Genotipo , Glutamina , Humanos , Masculino , Datos de Secuencia Molecular , Resultado del Tratamiento , Agudeza VisualRESUMEN
SETTING: A medical centre in Taipei, Taiwan. OBJECTIVE: To investigate the clinicopathological and microbiological correlates of skin and soft tissue infection (SSTI) due to non-tuberculous mycobacteria (NTM). DESIGN: Patients with NTM SSTI identified from 1999 to 2009 were included. Histological sections of the skin biopsy specimens from these patients were reassessed. RESULTS: Among 58 patients with NTM SSTI, the most commonly isolated NTM were rapidly growing mycobacteria (RGM; n = 30), Mycobacterium marinum (n = 17) and M. avium complex (MAC) (n = 4). Twenty-nine (50%) of the NTM SSTI involved deep soft tissue; these progressed to local tenosynovitis in 20 patients. All of the cutaneous lesions infected with M. marinum occurred on the upper extremities; in 9 patients the skin eruptions developed after injury in an aquatic environment. Skin lesions with RGM infection usually occurred on the lower extremities, and in 6 patients the infection developed from wounds caused by medical procedures. Granulomatous inflammation with fibrinoid necrosis was present in 47% of lesions in patients with M. marinum infection and suppurative granulomatous inflammation was noted in 45% of patients with RGM infection. CONCLUSIONS: Identification of a close clinicopathological correlate is useful for dermatologists and pathologists in the early diagnosis and treatment of NTM SSTI.
Asunto(s)
Infecciones por Mycobacterium no Tuberculosas/diagnóstico , Enfermedades Cutáneas Bacterianas/diagnóstico , Enfermedades Cutáneas Bacterianas/microbiología , Infecciones de los Tejidos Blandos/diagnóstico , Infecciones de los Tejidos Blandos/microbiología , Adolescente , Adulto , Anciano , Antituberculosos/uso terapéutico , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Infecciones por Mycobacterium no Tuberculosas/tratamiento farmacológico , Infecciones por Mycobacterium no Tuberculosas/epidemiología , Micobacterias no Tuberculosas/clasificación , Micobacterias no Tuberculosas/aislamiento & purificación , Factores de Riesgo , Enfermedades Cutáneas Bacterianas/tratamiento farmacológico , Infecciones de los Tejidos Blandos/tratamiento farmacológico , Taiwán/epidemiología , Resultado del Tratamiento , Adulto JovenAsunto(s)
Fasciola hepatica/patogenicidad , Fascioliasis/parasitología , Absceso Hepático/parasitología , Adulto , Animales , Biopsia , Enfermedad Crónica , Fascioliasis/complicaciones , Fascioliasis/diagnóstico , Femenino , Hepatectomía , Humanos , Absceso Hepático/diagnóstico , Absceso Hepático/cirugía , Tomografía Computarizada por Rayos X , Resultado del TratamientoRESUMEN
We report the growth of needle-like high density quaternary ZnCdSeTe nanowires on oxidized Si(100) substrate using vapor-liquid-solid mechanism by molecular beam epitaxy with an Au-based nanocatalyst. It was found that average length and average diameter of the nanowires were 1.3 microm and 91 nm, respectively. It was also found that the as-grown ZnCdSeTe nanowires exhibit mixture of cubic zinc-blende and hexagonal wurtzite structures. Energy depersive results indicate that composition ratio of our nanowire should be Zn0.87Cd0.13Se0.98Te0.02, which agrees excellently with the designated composition ratio of Zn0.87Cd0.13Se0.98Te0.02.
RESUMEN
PURPOSE: To access the feasibility of using cultivated oral mucosal epithelial cell transplantation (COMET) for the management of severe corneal burn. METHODS: COMET was performed to promote re-epithelialization in two eyes with acute alkaline burn and one eye with chronic alkaline burn, and to reconstruct the ocular surface in two eyes with chronic thermal burn. Autologous oral mucosal epithelial cells obtained from biopsy were cultivated on amniotic membrane. Immunoconfocal microscopy for keratins and progenitor cell markers was performed to characterize the cultivated epithelial sheet. Following transplantation, the clinical outcome and possible complications were documented. The patients were followed for an averaged 29.6+/-3.6 (range: 26-34) months. RESULTS: Cultivated oral mucosal epithelial sheet expressed keratin 3, 13, and progenitor cell markers p63, p75, and ABCG2. After COMET, all the corneas became less inflamed, and the corneal surface was completely re-epithelialized in 6.0+/-3.2 (range: 3-10) days in all but one patients. Microperforation occurred in one patient, and a small persistent epithelial defect developed in another. Both were solved uneventfully. In all patients, superficial corneal blood vessels invariably developed, and to further improve vision, conjunctivo-limbal autografting (N=3) and/or penetrating keratoplasty (N=3) were performed subsequently. The vision of all patients showed substantial improvement after additional surgeries. CONCLUSIONS: This study showed the potential of COMET to promote re-epithelialization and reduce inflammation in acute corneal burn, and to reconstruct the corneal surface in chronic burn. COMET may, therefore, be considered an alternative treatment for severe corneal burn.
Asunto(s)
Trasplante de Células , Lesiones de la Cornea , Células Epiteliales/trasplante , Quemaduras Oculares/cirugía , Mucosa Bucal/citología , Adolescente , Adulto , Amnios/trasplante , Biomarcadores/metabolismo , Quemaduras Químicas/cirugía , Técnicas de Cultivo de Célula/métodos , Células Cultivadas , Células Epiteliales/metabolismo , Epitelio Corneal/patología , Epitelio Corneal/cirugía , Quemaduras Oculares/patología , Estudios de Factibilidad , Humanos , Queratinas/metabolismo , Masculino , Persona de Mediana Edad , Ingeniería de Tejidos/métodos , Trasplante Autólogo , Adulto JovenAsunto(s)
Anticonvulsivantes/efectos adversos , Carbamazepina/análogos & derivados , Antígenos HLA-B/genética , Síndrome de Stevens-Johnson/inducido químicamente , Carbamazepina/efectos adversos , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Oxcarbazepina , Síndrome de Stevens-Johnson/genética , Síndrome de Stevens-Johnson/inmunologíaAsunto(s)
Lesión Renal Aguda/terapia , Medios de Contraste/efectos adversos , Gadolinio/efectos adversos , Dermopatía Fibrosante Nefrogénica/inducido químicamente , Lesión Renal Aguda/complicaciones , Lesión Renal Aguda/fisiopatología , Adulto , Humanos , Imagen por Resonancia Magnética , Masculino , Dermopatía Fibrosante Nefrogénica/complicacionesRESUMEN
EBV-induced post transplant lymphoproliferative disorder (PTLD) continues to be a major complication after transplantation. Between January 1993 and April 2006, 12 cases of B-cell lymphoproliferative disorder were identified among 577 patients after allogeneic hematopoietic SCT (HSCT) with an overall incidence of 2.51% at 1 year. Grades II-IV acute GVHD, CMV antigenemia and the use of antithymocyte globulin (ATG) were independent risk factors for PTLD. At diagnosis, all of the tumors were CD20-positive and 11 (92%) were EBV-encoded RNA (EBER)-positive. Of the 12 patients with B-cell lymphoproliferative disorder, 8 had pulmonary involvement and 10 had extranodal involvement. Eleven patients received weekly rituximab therapy at a dose of 375 mg/m(2); the median interval between the onset of symptoms and rituximab therapy was 6 days. The overall mortality rate was 92% and seven (64%) of the deaths were directly attributable to disseminated PTLD within days or weeks of presentation. In our series, pulmonary PTLD followed an extremely aggressive course and poor response to current therapy, even though rituximab was included in the therapeutic regimens.
Asunto(s)
Trasplante de Células Madre Hematopoyéticas/efectos adversos , Enfermedades Pulmonares/etiología , Trastornos Linfoproliferativos/etiología , Adolescente , Adulto , Anticuerpos Monoclonales/uso terapéutico , Anticuerpos Monoclonales de Origen Murino , Niño , Preescolar , Estudios de Cohortes , Infecciones por Virus de Epstein-Barr/etiología , Infecciones por Virus de Epstein-Barr/inmunología , Infecciones por Virus de Epstein-Barr/terapia , Femenino , Humanos , Lactante , Enfermedades Pulmonares/inmunología , Enfermedades Pulmonares/terapia , Trastornos Linfoproliferativos/inmunología , Trastornos Linfoproliferativos/terapia , Masculino , Persona de Mediana Edad , Análisis Multivariante , Factores de Riesgo , Rituximab , Trasplante Homólogo , Resultado del Tratamiento , Adulto JovenAsunto(s)
Inhibidores de la Enzima Convertidora de Angiotensina/efectos adversos , Dermatitis Exfoliativa/inducido químicamente , Erupciones por Medicamentos/etiología , Enalapril/efectos adversos , Granuloma/inducido químicamente , Anciano , Dermatitis Exfoliativa/patología , Erupciones por Medicamentos/patología , Granuloma/patología , Humanos , Hipertensión/tratamiento farmacológico , MasculinoRESUMEN
BACKGROUND: To survey the accuracy of fetal gender determination during first trimester screening and scan for congenital anomalies. METHODS: A prospective observational study was performed on 496 singleton pregnancies at the first trimester ultrasound screening. The doctor was a certified sonographer of first trimester screening by the Fetal Medicine Foundation(FMF). Ultrasound examination was performed on a GE Voluson 730 Pro, transabdominally, between 11 and 13(+6) weeks. Both transverse and mid-sagittal planes of a section of the fetal genital tubercle were performed to identify the gender. The subsequent gender at birth was obtained from karyotyping reports or hospital birth records. RESULTS: During the study, 496 patients requested gender information at the time of first trimester screening. Of the patients it was possible to determine gender (441 out of 496), the scan achieved an overall success rate of 91.8% in correctly identifying gender. The success rate for correctly identifying fetal gender (where identification was possible) increased with gestational age, from 71.9% at 11 weeks, 92% at 12 weeks, and 98.3% at 13 weeks, respectively, where gestational age was calculated from the crown-rump length in conjunction with menstrual or ovulation dating (p<0.001). Of the 55 cases where no identification of gender was possible, 39 were in the 11-week gestational age group, representing 40.6% of this category. The overall fetal gender accuracy rate for male fetus was slightly better than female (92.5 versus 91.2%), but was not statistically significant. CONCLUSIONS: This study demonstrated that the gestational age of the fetus has a material effect on the accuracy rate of gender determination. At 12 weeks and over, the average success rate for correctly identifying gender, where gender identification was possible, was 94.8%, with the accuracy at 13 weeks of 98.3% approaching that achieved by invasive testing. Fetal gender identification at 11
Asunto(s)
Análisis para Determinación del Sexo/métodos , Ultrasonografía Prenatal/métodos , Femenino , Edad Gestacional , Humanos , Recién Nacido , Masculino , Valor Predictivo de las Pruebas , Embarazo , Primer Trimestre del Embarazo , Estudios Prospectivos , Análisis para Determinación del Sexo/normas , Ultrasonografía Prenatal/normasRESUMEN
The aim of the present study was to investigate whether imprint cytology can improve the diagnostic accuracy of computed tomography-guided transthoracic core biopsy. Between October 1997 and June 2004, thoracic lesions in 622 patients underwent biopsy using 19-gauge coaxial guiding needles and 20-gauge biopsy needles under computed tomography guidance. Touch imprint cytology and histopathology were performed for all biopsy specimens. Of these lesions, 431 (74.1%) were diagnosed as malignant, 151 (25.9%) as benign and 40 (6%) as nondiagnostic. Imprint cytology plus histology shows an improved diagnostic accuracy of 96.4% compared with that of imprint cytology alone (92.3%) or histopathology alone (93.0%). Procedure-related complications requiring further treatment occurred in eight (1.4%) patients. In conclusion, imprint cytology combined with histopathology can improve the diagnostic accuracy of computed tomography-guided transthoracic needle biopsy.
Asunto(s)
Técnicas Citológicas , Enfermedades Pulmonares/diagnóstico , Nódulo Pulmonar Solitario/diagnóstico , Tomografía Computarizada por Rayos X/métodos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Biopsia , Biopsia con Aguja , Femenino , Humanos , Enfermedades Pulmonares/patología , Masculino , Persona de Mediana Edad , Reproducibilidad de los Resultados , Nódulo Pulmonar Solitario/patologíaAsunto(s)
Diálisis Peritoneal , Enfermedades de la Piel/diagnóstico , Anciano , Antígenos CD/metabolismo , Antígenos CD34/metabolismo , Factor XIIIa/metabolismo , Resultado Fatal , Femenino , Fibrosis/patología , Humanos , Inmunohistoquímica , Fallo Renal Crónico/complicaciones , Fallo Renal Crónico/patología , Fallo Renal Crónico/terapia , Enfermedades de la Piel/patología , Factores de TiempoAsunto(s)
Micosis Fungoide/etiología , Pitiriasis Liquenoide/complicaciones , Neoplasias Cutáneas/etiología , Antígenos CD8/análisis , Dexametasona/uso terapéutico , Diagnóstico Diferencial , Femenino , Glucocorticoides/uso terapéutico , Humanos , Persona de Mediana Edad , Micosis Fungoide/tratamiento farmacológico , Micosis Fungoide/inmunología , Micosis Fungoide/patología , Pitiriasis Liquenoide/patología , Reacción en Cadena de la Polimerasa , Neoplasias Cutáneas/inmunología , Neoplasias Cutáneas/patologíaRESUMEN
Basal cell carcinoma (BCC) is one of the most common skin neoplasms in humans and is usually characterized by local aggressiveness with little metastatic potential, although deep invasion, recurrence, and regional and distant metastases may occur. Here, we studied the mechanism of BCC invasion. We found that human BCC tissues and a BCC cell line had significant expression of CXCR4, which was higher in invasive than non-invasive BCC types. Further, of 19 recurrent tumors among 390 BCCs diagnosed during the past 12 years, 17/19 (89.5%) had high CXCR4 expression. We found that the CXCR4 ligand, stromal-cell-derived factor 1alpha (SDF-1alpha), directed BCC invasion and that this was mediated by time-dependent upregulation of mRNA expression and gelatinase activity of matrix metalloproteinase-13 (MMP-13). The transcriptional regulation of MMP-13 by SDF-1alpha was mediated by phosphorylation of extracellular signal-related kinase 1/2 and activation of the AP-1 component c-Jun. Finally, CXCR4-transfected BCC cells injected into nude mice induced aggressive BCCs that co-expressed CXCR4 and MMP-13. The identification of SDF-1alpha/CXCR4 as an important factor in BCC invasiveness may contribute insight into mechanisms involved in the aggressive potential of human BCC and may improve therapy for invasive BCCs.